CXCL8 and inflammatory bowel disease: The two most active indanes 2 and 8 with the hydroxyl group at C-1 had been shown to have potential for the treatment of IBD in previous studies.[4,9] This study shows that they inhibit the key mediators IL-6 and TNF-α in THP-1 macrophages and IL-8 in SW480 cells.